CLINIC
Can Zaynich do for Wockhardt what Ozempic did for Novo Nordisk?
Wockhardt's Zaynich antibiotic surged stock by 75%. CEO Habil Khorakiwala cited its uniqueness; phase three trials end this fiscal year. Compared to Novo Nordisk's Ozempic, Zaynich’s $25 billion potential counters global antibiotic resistance.
Dental appointments in Costa del Sol are cheaper than private clinics in the UK. Here is the reason
A women realised that travelling to Costa del Sol in Spain for a dental appointment is a lot cheaper than spending on a private clinic in the UK. This cost is cheaper including the appointment charges, flight tickets and an overnight stay. People are finding creative solutions to tackle the challenges of getting timely appointment at the NHS.
Sun Pharma-Moebius Medical anti-osteoarthritis injection shows sustained pain relief in clinical trials
Sun Pharma and Moebius Medical announced that their intra-articular injection MM-II showed greater pain relief than placebo for up to 26 weeks in osteoarthritis (OA) patients, based on clinical trial data. The study demonstrated that from weeks 12 to 26, more patients on MM-II experienced significant pain improvement compared to those on placebo. MM-II, a novel non-opioid, uses a proprietary suspension of liposomes to reduce joint friction and pain. The companies plan to initiate a Phase 3 clinical program and seek a CE Mark for the product in the European Union.
‘Kerala Story’ actress Adah Sharma reveals she has endometriosis; 42 mn Indian women live with this painful condition
Actress Adah Sharma recently shared details about a challenging health diagnosis. The 'Kerala Story' star revealed she is suffering from endometriosis. In an interview with the Hindustan Times, she mentioned that fluctuating between being thin and plump for different roles might have contributed to her diagnosis.
Artificial sweetners in chewing gum and even toothpaste can give you blood clots, heart attacks or stroke: Study
Artificial sweeteners, particularly xylitol, may pose health risks by affecting platelets and blood clotting, leading to cardiovascular events. Caution is advised, with recommendations for natural sweeteners and occasional use of xylitol products for those at risk.
Are energy drinks linked to heart attack risk? This is what latest research says
Recent research has linked the consumption of energy drinks to a higher incidence of heart attacks. It is also known to cause other issues which affect the mental health of individuals.
- Go To Page 1
CDSCO panel gives nod for continuation of phase-II clinical trial of SII's dengue vaccine
An expert committee recommended continuation of phase-II clinical trial of Serum Institute of India's vaccine against dengue after successful phase-I interim trial in Australia. The SEC recommendations were made on May 31.
Now, a 'Bank Clinic' to guide you on complaints
The Bank Clinic is an initiative by the All India Bank Employees' Association (AIBEA) to help customers address their grievances amid rapid expansion in technology and a series of Reserve Bank of India (RBI) guidelines on retail banking. A customer can fill out the details of her/his complaint, create a ticket, and receive a reply in five working days on the remedies available and information on what the RBI guidelines prescribe on that matter.
GSK blood cancer drug nearly halves risk of death in late-stage trial
In the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who received Blenrep in combination with the steroid dexamethasone and pomalidomide were alive without their disease worsening at the end of a year. That compared with progression-free survival (PFS) of 51% of those who were treated with pomalidomide, dexamethasone and bortezomib. Pomalidomide is a generic version of Bristol Myers Squibb's Pomalyst, while bortezomib is the generic of Takeda Pharmaceuticals' Velcade.
Google is using AI to answer your health questions. Should you trust it?
Google AI Overviews, utilizing generative AI, presents search answers with a mix of reputable and commercial sources. Experts raise concerns about accuracy and clarity in medical responses, emphasizing the need for critical evaluation and reliance on trusted sources.
Pfizer drug extends life for people with rare form of lung cancer
A Pfizer lung cancer drug has been shown to greatly reduce tumor progression and improve survival outcomes for people in the advanced stages of a rare form of the disease, according to trial results published Friday.
Gene-based drugs show promise in lowering cholesterol levels, reveals new studies
The studies published in the New England Journal of Medicine highlight the potential of gene-based drugs in lowering cholesterol levels in individuals with naturally high lipid levels. These drugs, plozasiran and zodasiran, are RNA-based and target specific proteins involved in cholesterol regulation. They were found to significantly reduce triglyceride levels in patients with mixed hyperlipidemia, even those already taking cholesterol-lowering statins.
Elon Musk's Neuralink seeks to enroll three patients in brain implant study
Neuralink, Elon Musk's brain-chip company, is conducting a study to evaluate its device for paralyzed patients to control digital devices through thoughts alone, facing criticism for lack of study information sharing.
HPV vaccines may protect men as well as women from cancer claims new study
Vaccinated women had a lower risk of developing cervical cancer within at least five years of getting the shots. For men, there were benefits too. Vaccinated men had a lower risk of developing any HPV-related cancer, such as cancers of the anus, penis and mouth and throat.
SII commences shipments of malaria vaccine 'R21/Matrix-M' to Africa
Serum Institute of India (SII) commenced exporting the 'R21/Matrix-M' malaria vaccine to Africa in collaboration with the University of Oxford and Novavax. The initial shipment, directed to the Central African Republic, is part of efforts to combat malaria in endemic regions, with further doses earmarked for South Sudan and the Democratic Republic of Congo.
Elon Musk arrives in Indonesia's Bali to launch Starlink satellite internet service
Elon Musk launched Starlink in Bali with President Joko Widodo and Luhut Binsar Pandjaitan, signing agreements for internet services. He also participated in the World Water Forum. Notable visits by Tim Cook and Satya Nadella for investment in Indonesia.
Founder Sachdev to retain majority stake in Centre for Sight
The Padma Shri awardee, who previously headed the ophthalmology department at All India Institute of Medical Sciences, told ET that he would be among the few entrepreneurs in this sector to remain in control of his company after private equity investors swamped the space announcing a slew of investments in the past 24 months.
Who was Kimberley Nix? What did TikTok influencer say in last video made before death? Everything about her
TikTok influencer Kimberley Nix worked as a resident doctor and was diagnosed with palliative sarcoma cancer at the age of 28. She used the platform to spread awareness of sarcoma cancer, a group of cancers that begin in the bones and soft tissues.
Dr Lal PathLabs Q4 Results: Net profit rises 51% YoY to Rs 86 crore on improved volumes of diagnostic tests
Dr Lal PathLabs on Friday reported a 51% year-on-year (YoY) jump in net profit to Rs 86 crore in the quarter ended March 2024 led by improved volumes of diagnostic tests.
Pfizer reports patient death in Duchenne gene therapy study
The trial is testing boys 2 to three years of age with DMD, a genetic muscle wasting disorder in which most patients lack the protein dystrophin which keeps muscles intact. The disorder affects an estimated one-in-3,500 male births worldwide.
CM jailed before polls to stifle his voice: Sunita Kejriwal calls for vote against 'dictatorship'
Sunita Kejriwal said her husband was put in jail since he built good government schools, mohalla clinics and promised to give Rs 1,000 to every woman in Delhi.
Manipal Hospitals to acquire Kolkata's Medica Synergie
Manipal Hospitals has acquired an 87% stake in Kolkata-based Medica Synergie, a subsidiary of Singapore's Temasek Holdings. The deal, valued at Rs1200 crore, is part of Manipal Hospitals' strategy to expand its presence in Eastern India. The acquisition comes after Sheares Health, the healthcare platform owned by Singapore's Temasek Holdings, acquired an additional 41% stake from existing investors and the promoter family for Rs16,500 crore.
India becoming attractive for clinical trials, says pharma industry leaders
Over the past decade, India has seen significant improvements in its clinical trial landscape, with a 15-18% growth in phase two and three trials. This growth is attributed to 10 modifications to the Drugs and Cosmetics Act since 2013, aimed at simplifying the process. Despite these advancements, conducting trials in India can still be challenging. Experts note that India's modernizing private hospital networks and improved infrastructure make it an attractive location for trials, with potential for further growth and collaboration in the future.
AAP government distributes fake medicines in Mohalla Clinics: BJP's Bansuri Swaraj
BJP leader Bansuri Swaraj criticized the Aam Aadmi Party (AAP) and Delhi Chief Minister Arvind Kejriwal, alleging poor conditions in Mohalla Clinics in the city. Swaraj claimed that fake medicines are being distributed in these clinics and that administrative staff, not doctors, are treating patients. She contrasted this with Prime Minister Modi's distribution of high-quality and affordable medicines through Janaushadhi Kendra.
Bharat Biotech starts clinical trials of TB jab
The only vaccine in use today--BCG (Bacillus Calmette and Guerin)--is an attenuated variant of the bovine TB pathogen. This is more than a hundred years old and has a limited effect on pulmonary tuberculosis, which is mostly responsible for the transmission of the disease. Studying the safety, immunogenicity and efficacy of MTBVAC in the most populated country in the world and the one with the highest number of cases of this infectious disease is key to continue advancing in this vaccine," the company said.
'Will send you to jail': Court warns Delhi health minister Saurabh Bharadwaj
Delhi High Court has warned Health Minister and Secretary of potential imprisonment for failing to enact laws regulating clinical establishments, emphasizing their duty to serve the public. Conflict over legislation delays draws court's ire, urging practical solutions over bureaucratic disputes. Petition highlights risks of unregulated labs. Officials face mounting pressure to address regulatory deficiencies promptly or face consequences.
Load More
